Andaman7 argues case for greater patient mediated research at HIMSS European Health Conference 2022

Vincent Keunen, CEO and Founder of Andaman7, to share best practice for implementing a patient-centered approach to effectively engage people in the transformation of digital health

Liege, Belgium – 14 June, 2022: ‘Data undoubtedly is the golden thread within healthcare, but the challenge lies in promoting willingness to both share, and use health data for primary and secondary use.’ That is the argument for a key session at the 2022 HIMSS European Health Conference, where Vincent Keunen, CEO and Founder of Belgian-American digital health company Andaman7, will participate with other HIMSS Digital Influencers and thought leaders to focus on ‘acceptance, adoption and attitudes towards data sharing, including discussion of the various sources of health data and interoperability, touching on implemented strategies for building trust across all stakeholders; citizens, clinicians, patients and researchers.’

The European conference is part of a wide-ranging response to mitigate the economic and social impact of the coronavirus pandemic, with the EU investing €673bn in “recovery and resilience,” of which at least €13bn targets investment in digital health transformation. Building back stronger and more resilient health systems is the key objective for national digital transformation programs, requiring healthcare and IT leaders to look at greater collaboration across the ecosystem.

Commenting on his participation, Vincent Keunen says:

“Having experience as both a cancer patient and digital health solutions provider, I understand first-hand what is needed, both to shape the future of technology and to improve access to care for patients.          

“Disruptive developments such as telemedicine, remote patient monitoring, and interoperability of patient electronic records is shifting power and accountability for healthcare into patients’ hands. Patient mediated research is the next stage - from automated Patient Reported Outcomes (PROs), through Hospital and Patient Health Records (PHR), to Medication Adherence Data for both prescribed and over the counter (OTC) drugs. This additional focus on the use of Real-world data (RWD) and real-world evidence (RWE) will play an increasing role in health care and regulatory decision making, including approval of new indications for approved drugs.”

The session, entitledBuilding and Maintaining Trust in the use of Health Data will take place Thursday 16 June, 2022 from 10:45-11:45 am   LOCAL TIME Helsinki.

Moderator:  Dr Petra Wilson, (UK). Senior Advisor, European Health Policy & EU Affairs, HIMSS will be speaking with:

−        Mr Vincent Keunen (Belgium) CEO & Founder, Andaman7. Patient advocate.

−      Prof. Sally Lewis (UK) Director of the Welsh Value in Health Centre / National Clinical Lead for Value-Based and Prudent Healthcare, NHS Wales 

−         Dr Said Shadi, Chief Digital Officer, Welsh Value in Health Centre, NHS Wales

−         Dr Seemit Dhage Head of Healthcare EMEA, Service Now. 

The 2022 HIMSS European Health Conference & Exhibition in Helsinki, Finland, from 14 to 16 June 2022 will cover themes including digital transformation, cybersecurity, interoperability, and data into knowledge.

For more information visit: https://www.himss.org/event-himss-europe

- END –

About Vincent Keunen 

Vincent Keunen is the founder and CEO of Andaman7.  Previously, he developed numerous medical IT systems (a secure data exchange platform used by more than 90% of Belgian hospitals and family doctors, and a prevention EHR, managing today close to 1 million patients).  Vincent was also the CIO of success story Lampiris and was awarded the CIO of the year prize for his work there.  When Vincent was diagnosed with leukaemiain 2007, and his 10-year-old son was diagnosed with bone cancer 3 months later, he decided to use his software engineering skills to provide all patients with a tool to manage their health information on their smartphone. That platform can now be used to improve medical research by collecting RWE (Real World Evidence) and PRO (Patient Reported Outcomes) while facilitating telemedicine, remote patient monitoring, and continuity of care. 

Find out more about Vincent Keunen’s personal story at http://bit.ly/a7vkblogen. 

About Andaman7 

Andaman7 is a Belgian-American eHealth company and was created to significantly improve communication and efficiency in collaboration between healthcare actors: patients, doctors, and researchers. The company’s particular strengths are in RWE, QoL, PRO studies. Andaman7‘s patient centric health intermediation platform is designed to: 

1 - help patients better manage their health data  

2 - enable outcome measurement for pharma and research  

3 - support disease management for hospitals and doctors.   

Andaman7’s unique "security by design and privacy by default" architecture does not store medical data in the cloud. Data is only stored on the edge of the network (on mobile devices) and exchanged in a distributed peer to peer method. Andaman7 is compliant with GDPR and HIPAA and is also validated FDA 21 CFR part 11 and EU Annex 11 for clinical trials.  Andaman7 is in use by citizens of over 30 countries and available in 20 languages. 

For more detail, visit https://www.andaman7.com/

For media enquiries, contact: 

Amanda Leweson 

Discovery PR, on behalf of Andaman7 

Email: amanda@discovery-pr.com 

Mobile: +44 (0)7852 153 791